Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$9.41
-0.8%
$9.15
$7.11
$11.70
$1.27B1.581.44 million shs509,100 shs
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$7.01
-1.0%
$4.77
$3.67
$7.61
$1.46B1.95524,272 shs690,319 shs
Enhabit, Inc. stock logo
EHAB
Enhabit
$7.97
+5.4%
$7.95
$6.47
$10.90
$403.24M1.68454,293 shs210,100 shs
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$18.07
-2.5%
$16.33
$9.90
$27.20
$1.47B0.42892,744 shs366,678 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
0.00%+3.16%+2.82%+5.45%-9.37%
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
0.00%+15.31%+78.79%+24.21%+42.45%
Enhabit, Inc. stock logo
EHAB
Enhabit
0.00%-0.59%+11.05%-28.93%-9.81%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
0.00%+12.98%+12.23%+44.62%+19.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
3.8784 of 5 stars
3.53.00.00.02.21.73.1
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
1.9055 of 5 stars
2.14.00.00.03.12.50.0
Enhabit, Inc. stock logo
EHAB
Enhabit
1.9187 of 5 stars
1.23.00.00.02.81.72.5
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
1.7513 of 5 stars
4.40.00.00.02.00.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
3.00
Buy$13.4042.45% Upside
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
2.00
Hold$6.45-7.95% Downside
Enhabit, Inc. stock logo
EHAB
Enhabit
2.33
Hold$8.678.81% Upside
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
2.89
Moderate Buy$37.00104.75% Upside

Current Analyst Ratings Breakdown

Latest EHAB, AVAH, VRDN, and AHCO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$5.00 ➝ $6.75
8/11/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$9.00
8/8/2025
Enhabit, Inc. stock logo
EHAB
Enhabit
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.50
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$27.00 ➝ $30.00
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$45.00 ➝ $41.00
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$27.00 ➝ $26.00
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$28.00 ➝ $32.00
8/6/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$36.00 ➝ $34.00
7/21/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$6.25 ➝ $6.00
7/16/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$6.00 ➝ $5.00
7/2/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$5.50
(Data available from 8/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$3.26B0.39$3.76 per share2.50$11.72 per share0.80
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$2.02B0.72$0.16 per share43.18($0.64) per share-10.95
Enhabit, Inc. stock logo
EHAB
Enhabit
$1.03B0.39$4.31 per share1.85$10.92 per share0.73
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$300K4,918.93N/AN/A$6.09 per share2.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$90.42M$0.5417.429.701.062.49%5.01%1.77%11/4/2025 (Estimated)
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
-$10.93M$0.0887.41N/A0.85%-54.56%3.17%11/6/2025 (Estimated)
Enhabit, Inc. stock logo
EHAB
Enhabit
-$156.20M-$2.67N/A27.47N/A-12.84%2.72%1.25%11/5/2025 (Estimated)
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-$269.95M-$3.83N/AN/AN/A-112,806.88%-78.95%-49.91%N/A

Latest EHAB, AVAH, VRDN, and AHCO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.10$0.13+$0.03$0.10$263.39 million$266.10 million
8/6/2025Q2 2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-$1.00-$1.00N/A-$1.00$0.05 million$0.08 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
N/AN/AN/AN/AN/A
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
N/AN/AN/AN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
N/AN/AN/AN/AN/A
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.14
1.06
0.82
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
N/A
1.09
1.09
Enhabit, Inc. stock logo
EHAB
Enhabit
0.79
1.57
1.57
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
0.04
11.01
11.01

Institutional Ownership

CompanyInstitutional Ownership
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
82.67%
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
87.96%
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
N/A

Insider Ownership

CompanyInsider Ownership
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.55%
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
7.00%
Enhabit, Inc. stock logo
EHAB
Enhabit
3.40%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
0.65%
CompanyEmployeesShares OutstandingFree FloatOptionable
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
10,500135.30 million133.20 millionOptionable
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
33,500208.90 million194.27 millionOptionable
Enhabit, Inc. stock logo
EHAB
Enhabit
10,70050.69 million48.97 millionOptionable
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
5081.66 million81.13 millionOptionable

Recent News About These Companies

Research Analysts Set Expectations for VRDN Q3 Earnings
HC Wainwright Issues Positive Estimate for VRDN Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

AdaptHealth stock logo

AdaptHealth NASDAQ:AHCO

$9.41 -0.07 (-0.77%)
As of 03:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

Aveanna Healthcare stock logo

Aveanna Healthcare NASDAQ:AVAH

$7.01 -0.07 (-1.03%)
As of 03:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Enhabit stock logo

Enhabit NYSE:EHAB

$7.96 +0.41 (+5.36%)
As of 03:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Viridian Therapeutics stock logo

Viridian Therapeutics NASDAQ:VRDN

$18.07 -0.47 (-2.53%)
As of 03:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.